Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure. A meta-analysis

Gianluigi Savarese, Francesca Musella, Carmen D'Amore, Enrico Vassallo, Teresa Losco, Francesco Gambardella, Milena Cecere, Laura Petraglia, Gennaro Pagano, Luigi Fimiani, Giuseppe Rengo, Dario Leosco, Bruno Trimarco, Pasquale Perrone-Filardi

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Objectives: The goal of this study was to explore the association between changes in B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) plasma levels and risk of hospital admission for heart failure (HF) worsening in patients with chronic HF. Background: The relationship between BNP and NT-proBNP plasma levels and risk of cardiovascular events in patients with chronic HF has been previously demonstrated. However, it is unclear whether changes in BNP and NT-proBNP levels predict morbidity in patients with chronic HF. Methods: The MEDLINE, Cochrane, ISI Web of Science, and SCOPUS databases were searched for papers about HF treatment up to August 2013. Randomized trials enrolling patients with systolic HF, assessing BNP and/or NT-proBNP at baseline and at end of follow-up, and reporting hospital stay for HF were included in the analysis. Meta-regression analysis was performed to test the relationship between BNP and NT-proBNP changes and the clinical endpoint. Sensitivity analysis was performed to assess the influence of baseline variables on results. Egger's linear regression was used to assess publication bias. Results: Nineteen trials enrolling 12,891 participants were included. The median follow-up was 9.5 months (interquartile range: 6 to 18 months), and 22% of patients were women. Active treatments significantly reduced the risk of hospital stay for HF worsening. In meta-regression analysis, changes in BNP and NT-proBNP were significantly associated with risk of hospital stay for HF worsening. Results were confirmed by using sensitivity analysis. No publication bias was detected. Conclusions: In patients with HF, reduction of BNP or NT-proBNP levels was associated with reduced risk of hospital stay for HF worsening.

Original languageEnglish
Pages (from-to)148-158
Number of pages11
JournalJACC: Heart Failure
Volume2
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Natriuretic Peptides
Brain Natriuretic Peptide
Patient Admission
Meta-Analysis
Heart Failure
Length of Stay
Publication Bias
Regression Analysis
Systolic Heart Failure
MEDLINE

Keywords

  • B-type natriuretic peptide
  • BNP
  • Heart failure
  • Meta-analysis
  • N-terminal pro-B-type natriuretic peptide
  • NT-proBNP

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Savarese, G., Musella, F., D'Amore, C., Vassallo, E., Losco, T., Gambardella, F., ... Perrone-Filardi, P. (2014). Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure. A meta-analysis. JACC: Heart Failure, 2(2), 148-158. https://doi.org/10.1016/j.jchf.2013.11.007

Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure. A meta-analysis. / Savarese, Gianluigi; Musella, Francesca; D'Amore, Carmen; Vassallo, Enrico; Losco, Teresa; Gambardella, Francesco; Cecere, Milena; Petraglia, Laura; Pagano, Gennaro; Fimiani, Luigi; Rengo, Giuseppe; Leosco, Dario; Trimarco, Bruno; Perrone-Filardi, Pasquale.

In: JACC: Heart Failure, Vol. 2, No. 2, 2014, p. 148-158.

Research output: Contribution to journalArticle

Savarese, G, Musella, F, D'Amore, C, Vassallo, E, Losco, T, Gambardella, F, Cecere, M, Petraglia, L, Pagano, G, Fimiani, L, Rengo, G, Leosco, D, Trimarco, B & Perrone-Filardi, P 2014, 'Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure. A meta-analysis', JACC: Heart Failure, vol. 2, no. 2, pp. 148-158. https://doi.org/10.1016/j.jchf.2013.11.007
Savarese, Gianluigi ; Musella, Francesca ; D'Amore, Carmen ; Vassallo, Enrico ; Losco, Teresa ; Gambardella, Francesco ; Cecere, Milena ; Petraglia, Laura ; Pagano, Gennaro ; Fimiani, Luigi ; Rengo, Giuseppe ; Leosco, Dario ; Trimarco, Bruno ; Perrone-Filardi, Pasquale. / Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure. A meta-analysis. In: JACC: Heart Failure. 2014 ; Vol. 2, No. 2. pp. 148-158.
@article{4701e86fdc9e4b6b90f2ad6ffcab2871,
title = "Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure. A meta-analysis",
abstract = "Objectives: The goal of this study was to explore the association between changes in B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) plasma levels and risk of hospital admission for heart failure (HF) worsening in patients with chronic HF. Background: The relationship between BNP and NT-proBNP plasma levels and risk of cardiovascular events in patients with chronic HF has been previously demonstrated. However, it is unclear whether changes in BNP and NT-proBNP levels predict morbidity in patients with chronic HF. Methods: The MEDLINE, Cochrane, ISI Web of Science, and SCOPUS databases were searched for papers about HF treatment up to August 2013. Randomized trials enrolling patients with systolic HF, assessing BNP and/or NT-proBNP at baseline and at end of follow-up, and reporting hospital stay for HF were included in the analysis. Meta-regression analysis was performed to test the relationship between BNP and NT-proBNP changes and the clinical endpoint. Sensitivity analysis was performed to assess the influence of baseline variables on results. Egger's linear regression was used to assess publication bias. Results: Nineteen trials enrolling 12,891 participants were included. The median follow-up was 9.5 months (interquartile range: 6 to 18 months), and 22{\%} of patients were women. Active treatments significantly reduced the risk of hospital stay for HF worsening. In meta-regression analysis, changes in BNP and NT-proBNP were significantly associated with risk of hospital stay for HF worsening. Results were confirmed by using sensitivity analysis. No publication bias was detected. Conclusions: In patients with HF, reduction of BNP or NT-proBNP levels was associated with reduced risk of hospital stay for HF worsening.",
keywords = "B-type natriuretic peptide, BNP, Heart failure, Meta-analysis, N-terminal pro-B-type natriuretic peptide, NT-proBNP",
author = "Gianluigi Savarese and Francesca Musella and Carmen D'Amore and Enrico Vassallo and Teresa Losco and Francesco Gambardella and Milena Cecere and Laura Petraglia and Gennaro Pagano and Luigi Fimiani and Giuseppe Rengo and Dario Leosco and Bruno Trimarco and Pasquale Perrone-Filardi",
year = "2014",
doi = "10.1016/j.jchf.2013.11.007",
language = "English",
volume = "2",
pages = "148--158",
journal = "JACC: Heart Failure",
issn = "2213-1779",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure. A meta-analysis

AU - Savarese, Gianluigi

AU - Musella, Francesca

AU - D'Amore, Carmen

AU - Vassallo, Enrico

AU - Losco, Teresa

AU - Gambardella, Francesco

AU - Cecere, Milena

AU - Petraglia, Laura

AU - Pagano, Gennaro

AU - Fimiani, Luigi

AU - Rengo, Giuseppe

AU - Leosco, Dario

AU - Trimarco, Bruno

AU - Perrone-Filardi, Pasquale

PY - 2014

Y1 - 2014

N2 - Objectives: The goal of this study was to explore the association between changes in B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) plasma levels and risk of hospital admission for heart failure (HF) worsening in patients with chronic HF. Background: The relationship between BNP and NT-proBNP plasma levels and risk of cardiovascular events in patients with chronic HF has been previously demonstrated. However, it is unclear whether changes in BNP and NT-proBNP levels predict morbidity in patients with chronic HF. Methods: The MEDLINE, Cochrane, ISI Web of Science, and SCOPUS databases were searched for papers about HF treatment up to August 2013. Randomized trials enrolling patients with systolic HF, assessing BNP and/or NT-proBNP at baseline and at end of follow-up, and reporting hospital stay for HF were included in the analysis. Meta-regression analysis was performed to test the relationship between BNP and NT-proBNP changes and the clinical endpoint. Sensitivity analysis was performed to assess the influence of baseline variables on results. Egger's linear regression was used to assess publication bias. Results: Nineteen trials enrolling 12,891 participants were included. The median follow-up was 9.5 months (interquartile range: 6 to 18 months), and 22% of patients were women. Active treatments significantly reduced the risk of hospital stay for HF worsening. In meta-regression analysis, changes in BNP and NT-proBNP were significantly associated with risk of hospital stay for HF worsening. Results were confirmed by using sensitivity analysis. No publication bias was detected. Conclusions: In patients with HF, reduction of BNP or NT-proBNP levels was associated with reduced risk of hospital stay for HF worsening.

AB - Objectives: The goal of this study was to explore the association between changes in B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) plasma levels and risk of hospital admission for heart failure (HF) worsening in patients with chronic HF. Background: The relationship between BNP and NT-proBNP plasma levels and risk of cardiovascular events in patients with chronic HF has been previously demonstrated. However, it is unclear whether changes in BNP and NT-proBNP levels predict morbidity in patients with chronic HF. Methods: The MEDLINE, Cochrane, ISI Web of Science, and SCOPUS databases were searched for papers about HF treatment up to August 2013. Randomized trials enrolling patients with systolic HF, assessing BNP and/or NT-proBNP at baseline and at end of follow-up, and reporting hospital stay for HF were included in the analysis. Meta-regression analysis was performed to test the relationship between BNP and NT-proBNP changes and the clinical endpoint. Sensitivity analysis was performed to assess the influence of baseline variables on results. Egger's linear regression was used to assess publication bias. Results: Nineteen trials enrolling 12,891 participants were included. The median follow-up was 9.5 months (interquartile range: 6 to 18 months), and 22% of patients were women. Active treatments significantly reduced the risk of hospital stay for HF worsening. In meta-regression analysis, changes in BNP and NT-proBNP were significantly associated with risk of hospital stay for HF worsening. Results were confirmed by using sensitivity analysis. No publication bias was detected. Conclusions: In patients with HF, reduction of BNP or NT-proBNP levels was associated with reduced risk of hospital stay for HF worsening.

KW - B-type natriuretic peptide

KW - BNP

KW - Heart failure

KW - Meta-analysis

KW - N-terminal pro-B-type natriuretic peptide

KW - NT-proBNP

UR - http://www.scopus.com/inward/record.url?scp=84897493907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897493907&partnerID=8YFLogxK

U2 - 10.1016/j.jchf.2013.11.007

DO - 10.1016/j.jchf.2013.11.007

M3 - Article

VL - 2

SP - 148

EP - 158

JO - JACC: Heart Failure

JF - JACC: Heart Failure

SN - 2213-1779

IS - 2

ER -